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Respiratory insufﬁciency in term infants is usually caused by
meconium aspiration, sepsis, or pneumonia. Interstitial
lung disease, a heterogeneous group of diffuse lung diseases,
is a rare cause of respiratory insufﬁciency in newborns. A
new classiﬁcation of this group of lung diseases was estab-
lished by the Children’s Interstitial Lung Disease Network.1–6
In this case report, we present a full-term infant with
pulmonary interstitial glycogenosis (PIG) together with
bronchopulmonary dysplasia (BPD) like features.
Case Report
An 11-day-old Moroccan boy was transferred from another
neonatal intensive care unit (NICU) due to refractory pulmo-
nary hypertension requiring extracorporeal membrane oxy-
genation (ECMO). It was the mother’s fourth pregnancy,
which was uneventful. The parents were ﬁrst cousins, there
is no family history of respiratory problems. The boywas born
at a gestational age of 39 weeks and 3 days. Birth weight was
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Abstract Pulmonary interstitial glycogenosis (PIG) is a rare interstitial lung disease in the newborns.
We report on the clinical presentation and pathological ﬁndings of a full-term male infant
with pulmonary hypertension requiring extracorporealmembrane oxygenation (ECMO). An
open lung biopsy demonstrated interstitial changes resembling pulmonary interstitial
glycogenosis as well as bronchopulmonary dysplasia (BPD), without convincing evidence of
maturational arrest, infection, alveolar proteinosis, or alveolar capillary dysplasia. The boy
was treatedwith glucocorticoids and, after a fewdays,wasweaned from ECMO. A fewhours
later, the patient died due to acute severe pulmonary hypertension with acute right
ventricular failure. The etiology and underlying pathogenic mechanisms of PIG are
unknown. The clinical outcomes are quite varied. Deaths have been reported when PIG
exists with abnormal lung development and pulmonary vascular growth and congenital
heart disease. Nomortality has been reported in PIG together with BPD in full-term infants.
In this article, we reported on a full-term infant with interstitial changes resembling PIG and
BPD who expired despite no convincing evidence of an anatomical maturational arrest or
congenital heart disease.
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3,730 g and Apgar scores were 9 and 10 at 1 and 5 minutes,
respectively. Initially, he was discharged homewithout prob-
lems. After 1 day, parents sought medical attention due to
tachypnea and feeding problems, after which he was admit-
ted to the NICU for hypoxia. Cardiac ultrasound showed
normal cardiac anatomy and a patent ductus arteriosus
(PDA) with signs of persistent pulmonary hypertension of
the newborn (PPHN). Inhaled nitric oxide and inotropic
support were started. Antibiotics were started empirically,
though there were no signs of viral or bacterial infection.
With these interventions, his condition improved, but after
2 days, he became hypoxic again due to severe pulmonary
hypertension with right-to-left shunting through the PDA.
Surfactant was administered without any beneﬁcial effect.
Despite intensive treatment, the PPHN could not be reversed,
and the boy was referred to our center for extracorporeal
membrane oxygenation (ECMO). Cardiac ultrasound showed
a severe persistent pulmonary hypertension with suprasys-
temic pressures, enlarged right ventricle, and a continuous
right-to-left shunting through the PDA. Veno-venous ECMO
was started on day 10.
Chest radiographs (►Fig. 1) showed diffuse pulmonary
opacities consistent with atelectasis or edema. Because it was
impossible to wean the patient from ECMO support and due
to lack of a deﬁnitive diagnosis, an open lung biopsy was
performed on day 8 of ECMO treatment.
Histological examination of the biopsy showed partially
atelectatic and partially emphysematous lung parenchyma,
including interstitial emphysema. Radial alveolar count (RAC,
i.e., the number of alveoli in a subpleural acinus between the
central bronchiole and the visceral pleura) could bemeasured
at only one place in the biopsy and was four to ﬁve, which is
within the normal parameters (►Fig. 2a). Except for a few
remnants of hyaline membranes, the alveoli were empty.
Pneumocytes were enlarged and showed large round nuclei
with prominent nucleoli. The alveolar septa were widened
due to three factors: ﬁrst, therewere several accumulations of
histiocytic cells with abundant, clear cytoplasm. Second, the
amount of collagen ﬁbers was increased as demonstrated by
Elastica-Masson stain (►Fig. 2b). Finally, there was an
increase of interstitial smooth muscle bundles as shown by
an immunohistochemical SM1-staining (►Fig. 2c). Small
arterioles showed a constricted media, but no signiﬁcant
intimal proliferation or ﬁbrosis. An immunohistochemical
CD34 staining highlighted numerous capillaries at consider-
able distance from the alveolar surface, yet evenly distributed
in the septa. There was no misalignment of venous vessels. A
periodic acid Schiff (PAS) stain revealed some granular mate-
rial digestable by diastase, consistent with glycogen, in the
clear cytoplasm of the interstitial histiocytes (►Fig. 2e, f) In
summary, the presence of PAS-positive histiocytes led to the
diagnosis of PIG, whereas the interstitial increase of collagen
and smooth muscle bundles were interpreted as reparative
phase of BPD.7 Based on this biopsy, there was no convincing
evidence of an anatomical maturational arrest, infection,
alveolar proteinosis, or alveolar capillary dysplasia. The
distribution of the PAS positive histiocytes was somewhat
irregular, the largest concentrations being located at the
intersections of alveolar septa.
The boy was treated with glucocorticoids due to the
reported potential beneﬁcial effect in cases of PIG.2,8–12 After
a few days of prednisolone, we were able to take the patient
off ECMO. A fewhours later, the patient again developed acute
severe pulmonary hypertension with acute right ventricular
failure. There was no evidence of a pulmonary embolism
at this time. Maximal ventilator support with inhaled
nitric oxide failed, and the patient expired. Autopsy was
not permitted by the patient’s family.
Discussion
Pulmonary interstitial glycogenosis (PIG) is a rare and poorly
understood lung disorder.5,8,12,13Diagnosis can only bemade
by means of a lung biopsy. Its characteristic histological
ﬁnding is interstitial thickening due to increased mesenchy-
mal cellularity without evidence of inﬂammatory cells. The
inter-alveolar septa are expanded by oval- to spindle-shaped
cells with pale cytoplasm, indistinct cell membranes, and
Fig. 1 Chest radiographs. (a) Portable frontal chest radiograph 1 day after birth showed a normal conﬁguration of the heart. There are some
prominent interstitial markings bilateral. (b) Portable frontal chest radiograph 10 days after birth. Endotracheal tube is in a high position. ECMO
canula is in a good position. Interstitial markings bilateral consistent with atelectasis or edema. ECMO, extracorporeal membrane oxygenation.
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oval, bland nuclei. Staining with PAS shows patchy PAS-
positive diastase sensitive material within the cytoplasm of
these interstitial cells, indicating the presence of glycogen.
The true function of these interstitial cells is unclear, but is
probably similar to ﬁbroblastic cells.1,3,5,8,9 The interstitial
cells found in our patient’s lung biopsy matched this descrip-
tion, although the amount of cytoplasmatic PAS digestable
granules was not very large. We could not perform electron
microscopy, because our standard ﬁxation protocol for peri-
natal lung biopsies does not contain glutaraldehyde. There are
two patterns of PIG observed: a diffuse interstitial PIG
without growth abnormalities or patchy PIG involvement in
preterm patients with alveolar growth abnormalities.4,14,15
In our small biopsy, it was difﬁcult to determine the overall
distribution pattern of the diagnostic cells; we can state that it
was not entirely diffuse. PIG has been described as both an
isolated ﬁnding and an additional ﬁnding in abnormal lung
development and pulmonary vascular growth, hemodynam-
ically signiﬁcant cardiac disease, Hunter syndrome and
Noonan syndrome.4,11–13,15–19 At histological investigation
of our biopsy, the predominant features were interstitial
changes of the lung parenchyma resembling BPD, which we
don’t expect in a full term infant. However, the boywas all the
time artiﬁcially ventilated with high pressures potentially
contributing to lung damage which made differentiation
between a developmental disorder and secondary changes
due to ventilation difﬁcult. Therefore, as parameter of matu-
rity,we used the RAC,whichwaswithin normal limits.We are
aware of the fact that therewere only two bronchioli visible in
the slides; however, we assumed that we would have seen
more bronchioles if there had been signiﬁcant delay in the
development of alveoli. The walls of the smallest arterioles
Fig. 2 Histological aspects of open lung biopsy. (a) (50, H&E stain) scanning view: double arrow indicates radial alveolar count; (b) (100,
Elastica-van Masson stain): increase of interstitial collagen ﬁbers (arrows); (c) immunohistochemistry: arrows indicate increase of interstitial
smooth muscle cells (100, SM1 stain); (d) immunohistochemistry: some capillaries (simple arrow) are in touch with alveolar basal membrane,
but many (double arrow) are not (100, CD34 stain); (e and f) (PAS and PAS-D, 200) interstitial cells with PAS-positive cytoplasmatic granules
(arrows in ►Fig. 2e) which disappear after diastase treatment.
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were thickened due to an increase of smoothmuscle cells. We
considered these changes consistent with pulmonary hyper-
tension as a consequence of the interstitial changes. There
were no signs of alveolar capillary dysplasia and no misalign-
ment of pulmonary veins. Unfortunately, since autopsy was
not permitted, therewas no further possibility to obtainmore
lung tissue to exclude a sampling error. In summary, our
patient is a full-term infant with histological features of PIG
and bronchopulmonary dysplasia without an anatomical
maturation arrest or a misalignment of pulmonary veins.
But because of the technical limitations mentioned above,
and since no genetic tests for surfactant genes were
performed we cannot rule out a functional immature lung
nor can we decide with certainty if PIG alone caused PPHN or
if PPHN was due to the BPD like changes and PIG has to be
considered as an epiphenomenon. However, histological
signs of surfactant deﬁciency were not seen and PPHN was
already present shortly after birth, at a time point where
eventual BPD was not yet present.
All patients presenting with PIG demonstrated tachypnea
and hypoxemia, most of them immediately after birth or in
the ﬁrst 2 days of life. It has not been seen past 8 months of
age. The majority required assisted ventilation.1,4,6,8,9 In the
relatively small number of reported cases, there is a male
gender preference.8,10,20
Radiological ﬁndings of PIG are nonspeciﬁc. They vary
considerably, depending on whether there is any associated
underlying growth abnormality. Infants with PIG not associ-
ated with an underlying growth abnormality show progres-
sive bilateral hyperinﬂation and eventual evolution to diffuse
interstitial markings on their chest X-rays. High-resolution
computed tomography (CT) scan of the chest demonstrates
segmental, or subsegmental ground-glass opacities, interlob-
ular septal thickening, and reticular changes in a primarily
subpleural distribution with few centrilobular nodules.
Infants with PIG associated with underlying growth abnor-
malities, show multiple small scattered cystic changes of
variable size combined with underlying diffuse ground-glass
opacity, interlobular septal thickening and reticular changes
on CT.6,8,9,14
The etiology and underlying pathogenic mechanism of
PIG are unknown. There have been no reported associations
with glycogenoses or other metabolic diseases. The current
hypothesis is that this lung abnormality originates in utero
and is a developmental abnormality.4,8–13,16 Maybe is
patchy PIG associated with anatomical abnormal lung
development and pulmonary vascular growth is an early
development disorder and diffuse isolated PIG a late devel-
opment disorder.
Currently, there are no guidelines for the treatment of
PIG. Administration of glucocorticoids has been recom-
mended and has demonstrated a favorable outcome in
affected patients.2,8–12
The prognosis remains uncertain. The clinical outcomes
are quite varied. Deaths have been reported when PIG exists
with an abnormal lung development and pulmonary vascular
growth, and congenital heart disease. No mortality has been
reported in isolated PIG.4,11,13,19
In this article, we reported on a full-term infant with
features of PIG and BPD, who expired. There was no convinc-
ing evidence of an anatomical maturational arrest or a
congenital heart disease. It is also possible that our patient
had an undiagnosed genetic or pulmonary abnormality.
So maybe PIG is an epiphenomenon at lung development
disorders in different stages and is the prognosis depending
on the stage of the development disorder.16,18,20
In conclusion, our knowledge of incidence, etiology, and
pathogenesis of PIG is lacking. The diagnosis can bemade only
after lung biopsy demonstrates the characteristic histological
ﬁndings. The prognosis of PIG continues to evolve. Further
investigation beyond simple case reports is needed to thor-
oughly characterize this disorder.
Note
It is also possible that our patient had an undiagnosed
genetic or pulmonary abnormality.
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